Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines

International Journal of Hematology

Volumn 90, Issue 5, 2009, Pages 545-552

  Kanda, Junya ^a   Uchiyama, Tatsuki ^a   Tomosugi, Naohisa ^b   Higuchi, Masato ^b   Uchiyama, Takashi ^a,c   Kawabata, Hiroshi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

^c Kitano Hospital   (Japan)

Author keywords

Hepcidin; Interleukin 6; Leukemia inhibitory factor; Oncostatin M

Indexed keywords

HEPCIDIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; LUCIFERASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; ONCOSTATIN M; STAT PROTEIN;

ANEMIA; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ASSAY; GENE ACTIVATION; GENE MUTATION; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIMICROBIAL CATIONIC PEPTIDES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M;

EID: 73449106764     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0443-x     Document Type: Article

References (45)

1. A Krause S Neitz HJ Magert A Schulz WG Forssmann P Schulz-Knappe, et al. 2000 LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity FEBS Lett 480 147 150 10.1016/S0014-5793(00)01920-7 11034317 (Pubitemid 30682492)
2. CH Park EV Valore AJ Waring T Ganz 2001 Hepcidin, a urinary antimicrobial peptide synthesized in the liver J Biol Chem 276 7806 7810 10.1074/jbc. M008922200 11113131
3. NC Andrews 2008 Forging a field: the golden age of iron biology Blood 112 219 230 10.1182/blood-2007-12-077388 18606887
4. Y Kohgo K Ikuta T Ohtake Y Torimoto J Kato 2008 Body iron metabolism and pathophysiology of iron overload Int J Hematol 88 7 15 10.1007/s12185-008-0120-5 18594779
5. FB Sow WC Florence AR Satoskar LS Schlesinger BS Zwilling WP Lafuse 2007 Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis J Leukoc Biol 82 934 945 10.1189/jlb.0407216 17609338 (Pubitemid 47511054)
6. E Nemeth MS Tuttle J Powelson MB Vaughn A Donovan DM Ward, et al. 2004 Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2090 2093 10.1126/science.1104742 15514116 (Pubitemid 40007660)
7. T Ganz 2005 Hepcidin: a regulator of intestinal iron absorption and iron recycling by macrophages Best Pract Res Clin Haematol 18 171 182 10.1016/j.beha.2004.08.020 15737883 (Pubitemid 40298363)
8. C Pigeon G Ilyin B Courselaud P Leroyer B Turlin P Brissot, et al. 2001 A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload J Biol Chem 276 7811 7819 10.1074/jbc.M008923200 11113132
9. E Nemeth S Rivera V Gabayan C Keller S Taudorf BK Pedersen, et al. 2004 IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron-regulatory hormone hepcidin J Clin Invest 113 1271 1276 15124018
10. E Beutler 2007 Iron storage disease: facts, fiction and progress Blood Cells Mol Dis 39 140 147 10.1016/j.bcmd.2007.03.009 17540589 (Pubitemid 47126927)
11. GJ Anderson LW Powell 2002 HFE and non-HFE hemochromatosis Int J Hematol 76 203 207 10.1007/BF02982788 12416729
12. P Lee H Peng T Gelbart L Wang E Beutler 2005 Regulation of hepcidin transcription by interleukin-1 and interleukin-6 Proc Natl Acad Sci USA 102 1906 1910 10.1073/pnas.0409808102 15684062 (Pubitemid 40261985)
13. J Inamura K Ikuta J Jimbo M Shindo K Sato Y Torimoto, et al. 2005 Upregulation of hepcidin by interleukin-1 beta in human hepatoma cell lines Hepatol Res 33 198 205 10.1016/j.hepres.2005.08.005 16198622 (Pubitemid 41794207)
14. HL Collins 2008 Withholding iron as a cellular defence mechanism: friend or foe? Eur J Immunol 38 1803 1806 10.1002/eji.200838505 18546145
15. E Nemeth EV Valore M Territo G Schiller A Lichtenstein T Ganz 2003 Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein Blood 101 2461 2463 10.1182/blood-2002-10-3235 12433676 (Pubitemid 36857598)
16. H Kawabata N Tomosugi J Kanda Y Tanaka K Yoshizaki T Uchiyama 2007 Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease Haematologica 92 857 858 10.3324/haematol.10794 17550864 (Pubitemid 350155317)
17. PC Heinrich I Behrmann S Haan HM Hermanns G Muller-Newen F Schaper 2003 Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 1 20 10.1042/BJ20030407 12773095 (Pubitemid 37046923)
18. N Malik JC Kallestad NL Gunderson SD Austin MG Neubauer V Ochs, et al. 1989 Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M Mol Cell Biol 9 2847 2853 2779549
19. PS Linsley J Kallestad V Ochs M Neubauer 1990 Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M Mol Cell Biol 10 1882 1890 2325640
20. A Grenier M Dehoux A Boutten M Arce-Vicioso G Durand MA Gougerot-Pocidalo, et al. 1999 Oncostatin M production and regulation by human polymorphonuclear neutrophils Blood 93 1413 1421 9949186
21. TJ Brown MN Lioubin H Marquardt 1987 Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes. Synergistic antiproliferative activity of transforming growth factor beta 1, interferon-gamma, and oncostatin M for human melanoma cells J Immunol 139 2977 2983 3117884
22. I Znoyko N Sohara SS Spicer M Trojanowska A Reuben 2005 Expression of oncostatin M and its receptors in normal and cirrhotic human liver J Hepatol 43 893 900 10.1016/j.jhep.2005.04.020 16169119 (Pubitemid 41414516)
23. T Suda K Chida A Todate K Ide K Asada Y Nakamura, et al. 2002 Oncostatin M production by human dendritic cells in response to bacterial products Cytokine 17 335 340 10.1006/cyto.2002.1023 12061841 (Pubitemid 34928871)
24. CD Richards TJ Brown M Shoyab H Baumann J Gauldie 1992 Recombinant oncostatin M stimulates the production of acute phase proteins in HepG2 cells and rat primary hepatocytes in vitro J Immunol 148 1731 1736 1371787
25. H Baumann J Gauldie 1994 The acute phase response Immunol Today 15 74 80 10.1016/0167-5699(94)90137-6 7512342 (Pubitemid 24049800)
26. M Tanaka A Miyajima 2003 Oncostatin M, a multifunctional cytokine Rev Physiol Biochem Pharmacol 149 39 52 10.1007/s10254-003-0013-1 12811586
27. K Nakamura H Nonaka H Saito M Tanaka A Miyajima 2004 Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice Hepatology 39 635 644 10.1002/hep.20086 14999682 (Pubitemid 38337643)
28. N Murao M Ishigai H Yasuno Y Shimonaka Y Aso 2007 Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up Rapid Commun Mass Spectrom 21 4033 4038 10.1002/rcm.3319 18000836
29. DM Wrighting NC Andrews 2006 Interleukin-6 induces hepcidin expression through STAT3 Blood 108 3204 3209 10.1182/blood-2006-06-027631 16835372 (Pubitemid 44776963)
30. E Kemna P Pickkers E Nemeth H van der Hoeven D Swinkels 2005 Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS Blood 106 1864 1866 10.1182/blood-2005-03-1159 15886319 (Pubitemid 41208606)
31. N Tomosugi H Kawabata R Wakatabe M Higuchi H Yamaya H Umehara, et al. 2006 Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System Blood 108 1381 1387 10.1182/blood-2005-10-4043 16621968 (Pubitemid 44232041)
32. A Waterston M Bower 2004 Fifty years of multicentric Castleman's disease Acta Oncol 43 698 704 10.1080/02841860410002752 15764213 (Pubitemid 40066010)
33. P Lee H Peng T Gelbart E Beutler 2004 The IL-6- and lipopolysaccharide- induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes Proc Natl Acad Sci USA 101 9263 9265 10.1073/pnas.0403108101 15192150 (Pubitemid 38812863)
34. H Urbanska-Rys A Wiersbowska H Stepien T Robak 2000 Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma Eur Cytokine Netw 11 443 451 11022130
35. K Koskela TT Pelliniemi A Rajamaki K Pulkki K Remes 2000 Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis Eur J Haematol 65 52 56 10.1034/j.1600-0609.2000.90167.x 10914939 (Pubitemid 30432020)
36. S Sharma E Nemeth YH Chen J Goodnough A Huston GD Roodman, et al. 2008 Involvement of hepcidin in the anemia of multiple myeloma Clin Cancer Res 14 3262 3267 10.1158/1078-0432.CCR-07-4153 18519751
37. T Ganz G Olbina D Girelli E Nemeth M Westerman 2008 Immunoassay for human serum hepcidin Blood 112 4292 4297 10.1182/blood-2008-02-139915 18689548
38. DP Gearing NM Gough JA King DJ Hilton NA Nicola RJ Simpson, et al. 1987 Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor (LIF) EMBO J 6 3995 4002 3127201
39. NM Gough 1992 Molecular genetics of leukemia inhibitory factor (LIF) and its receptor Growth Factors 7 175 179 10.3109/08977199209046922 1457125
40. MA Brown D Metcalf NM Gough 1994 Leukaemia inhibitory factor and interleukin 6 are expressed at very low levels in the normal adult mouse and are induced by inflammation Cytokine 6 300 309 10.1016/1043-4666(94)90027-2 8054487 (Pubitemid 24263873)
41. DP Gearing 1993 The leukemia inhibitory factor and its receptor Adv Immunol 53 31 58 10.1016/S0065-2776(08)60497-6 8512038
42. V Lorgeot V Praloran P Turlure Y Denizot 1997 Concentrations of serum leukemia inhibitory factor (LIF) in patients with hematologic malignancies Leukemia 11 311 312 10.1038/sj.leu.2400570 9009099
43. V Koliaraki M Marinou TP Vassilakopoulos E Vavourakis E Tsochatzis GA Pangalis, et al. 2009 A novel immunological assay for hepcidin quantification in human serum PLoS One 4 e4581 10.1371/journal.pone.0004581 19238200
44. MV Verga Falzacappa M Vujic Spasic R Kessler J Stolte MW Hentze MU Muckenthaler 2007 STAT3 mediates hepatic hepcidin expression and its inflammatory stimulation Blood 109 353 358 10.1182/blood-2006-07-033969 16946298 (Pubitemid 46053077)
45. A Pietrangelo U Dierssen L Valli C Garuti A Rump E Corradini, et al. 2007 STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo Gastroenterology 132 294 300 10.1053/j.gastro.2006.10.018 17241879 (Pubitemid 46108739)